156 related articles for article (PubMed ID: 32140960)
1. Coenzyme Q10 in association with metabolism-related AMPK/PFKFB3 and angiogenic VEGF/VEGFR2 genes in breast cancer patients.
Abdi S; Montazeri V; Garjani A; Shayanfar A; Pirouzpanah S
Mol Biol Rep; 2020 Apr; 47(4):2459-2473. PubMed ID: 32140960
[TBL] [Abstract][Full Text] [Related]
2. Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer.
Rydén L; Linderholm B; Nielsen NH; Emdin S; Jönsson PE; Landberg G
Breast Cancer Res Treat; 2003 Dec; 82(3):147-54. PubMed ID: 14703061
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
[TBL] [Abstract][Full Text] [Related]
4. Coenzyme Q10 increases the fatty acid oxidation through AMPK-mediated PPARα induction in 3T3-L1 preadipocytes.
Lee SK; Lee JO; Kim JH; Kim N; You GY; Moon JW; Sha J; Kim SJ; Lee YW; Kang HJ; Park SH; Kim HS
Cell Signal; 2012 Dec; 24(12):2329-36. PubMed ID: 22885103
[TBL] [Abstract][Full Text] [Related]
5. Trolox aids coenzyme Q
Upreti S; Nag TC; Ghosh MP
Exp Eye Res; 2024 Jan; 238():109740. PubMed ID: 38056553
[TBL] [Abstract][Full Text] [Related]
6. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated VEGFR2 and hypertension: potential biomarkers to indicate VEGF-dependency of advanced breast cancer in anti-angiogenic therapy.
Fan M; Zhang J; Wang Z; Wang B; Zhang Q; Zheng C; Li T; Ni C; Wu Z; Shao Z; Hu X
Breast Cancer Res Treat; 2014 Jan; 143(1):141-51. PubMed ID: 24292957
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of plasma levels of coenzyme Q10 and lung cancer risk in a low-income population in the Southeastern United States.
Shidal C; Yoon HS; Zheng W; Wu J; Franke AA; Blot WJ; Shu XO; Cai Q
Cancer Med; 2021 Feb; 10(4):1439-1447. PubMed ID: 33547884
[TBL] [Abstract][Full Text] [Related]
9. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
10. Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
Goussia A; Simou N; Zagouri F; Manousou K; Lazaridis G; Gogas H; Koutras A; Sotiropoulou M; Pentheroudakis G; Bafaloukos D; Markopoulos C; Patsea H; Christodoulou C; Papakostas P; Zaramboukas T; Samantas E; Kosmidis P; Venizelos V; Karanikiotis C; Papatsibas G; Xepapadakis G; Kalogeras KT; Bamia C; Dimopoulos MA; Malamou-Mitsi V; Fountzilas G; Batistatou A
PLoS One; 2018; 13(7):e0200302. PubMed ID: 30063723
[TBL] [Abstract][Full Text] [Related]
11. Plasma coenzyme Q10 levels and postmenopausal breast cancer risk: the multiethnic cohort study.
Chai W; Cooney RV; Franke AA; Shvetsov YB; Caberto CP; Wilkens LR; Le Marchand L; Henderson BE; Kolonel LN; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2351-6. PubMed ID: 20668119
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
Bonnesen B; Pappot H; Holmstav J; Skov BG
Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway.
Chen K; Chen X; Xue H; Zhang P; Fang W; Chen X; Ling W
Food Funct; 2019 Feb; 10(2):814-823. PubMed ID: 30675881
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.
Kim M; Sohn M; Shim M; Choi SK; Park M; Kim E; Go H; Park Y; Cho YM; Ro JY; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
Hum Pathol; 2017 Mar; 61():78-89. PubMed ID: 27989785
[TBL] [Abstract][Full Text] [Related]
16. FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming.
Bhattacharya R; Ray Chaudhuri S; Roy SS
J Cell Biochem; 2018 Nov; 119(10):8174-8189. PubMed ID: 29904943
[TBL] [Abstract][Full Text] [Related]
17. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis.
Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
J Pathol; 2001 Mar; 193(3):325-32. PubMed ID: 11241411
[TBL] [Abstract][Full Text] [Related]
18. Regulatory Proteins of Epithelial-Mesenchymal Transition and Some Components of VEGF Signaling Pathway in Breast Cancer.
Scherbakov AM; Gershtein ES; Korotkova EA; Ovchinnikova LK; Ovsii OG; Ermilova VD; Gens GP; Kushlinskii NE
Bull Exp Biol Med; 2016 Apr; 160(6):802-6. PubMed ID: 27165081
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response.
Rydén L; Stendahl M; Jonsson H; Emdin S; Bengtsson NO; Landberg G
Breast Cancer Res Treat; 2005 Jan; 89(2):135-43. PubMed ID: 15692755
[TBL] [Abstract][Full Text] [Related]
20. Expression of VEGF and VEGFR2 in tumors during neoadjuvant therapy of patients with breast cancer.
Kim EA; Gershtein ES; Vysotskaya IV; Kushlinskii NE
Bull Exp Biol Med; 2008 Feb; 145(2):245-8. PubMed ID: 19023980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
